This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Journal and News Scan

Source: European Journal of Vascular and Endovascular Surgery
Author(s): Ross Naylor, Barbara Rantner, Stefano Ancetti, Gert J. de Borst, Marco De Carlo, Alison Halliday, Stavros K. Kakkos, Hugh S. Markus, Dominick J.H. McCabe, Henrik Sillesen, Jos C. van den Berg, Melina Vega de Ceniga, Maarit A. Venermo, Frank E.G. Vermassen, George A. Antoniou, Frederico Bastos Goncalves, Martin Bjorck, Nabil Chakfe, Raphael Coscas, Nuno V. Dias, Florian Dick, Robert J. Hinchliffe, Philippe KolhIgor, B. Koncar, Jes S. Lindholt, Barend M.E. Mees, Timothy A. Resch, Santi Trimarchi, Riikka Tulamo, Christopher P. Twine, Anders Wanhainen, Sergi Bellmunt-Montoya, Richard Bulbulia, R Clement Darling III, Hans-Henning Eckstein, Athanasios Giannoukas, Mark J.W. Koelemay, David Lindström, Marc Schermerhorn, David H. Stone

These updated guidelines give a comprehensive guide on the treatment of atheroscleritoc carotid and vertebral artery disease to prevent stroke and TIA.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Justin Ren, Andrea Bowyer, David H Tian, Christopher M Reid, Bridget Hwang, Colin Royse, Doa El-Ansary, Alistair Royse

This article investigates long term survival of total arterial coronary artery bypass grafting comparatively in a male versus female population. The retrospective analysis revealed that, compared to vein dependent procedures, total arterial revascularization was closely associated with a reduced incidence of long-term all-cause mortality for both male (HR, 0.86; 95 percent CI, 0.81–0.91; P < 0.001) and female (HR, 0.82; 95 percent CI, 0.73–0.91; P < 0.001) cohorts.

Source: tctMD
Author(s): Caitlin E. Cox

The device manufacturer Abiomed has issued a recall, issued Class I by the FDA, for its left-sided heart pumps due to cases in which the pump catheter has perforated the left ventricle wall. In its letter, Abiomed advised clinicians to carefully position the pump catheter, use imaging to aid in positioning, and to use caution in high-risk patients. It also specified that the recall is a correction, not a total product removal.

Source: European Journal of Cardiothoracic Surgery
Author(s): Mikolaj Berezowski, Saiesh Kalva, Joseph E Bavaria, Yu Zhao, William L Patrick, John J Kelly, Wilson Y Szeto, Joshua C Grimm, Nimesh D Desai

This study used the German registry of acute aortic dissection type A (GERAADA) score to predict thirty-day mortality in an aortic center in the United States. Six-hundred-eighty-five patients who underwent surgery for acute type A aortic dissection were included. Thirty-day mortality was 12 percent. The GERAADA score had very good discrimination power (area under the receiver operating characteristic 0.762). The observed versus estimated mortality ratio was 0.543, indicating the model overestimated risk. The authors concluded the GERAADA score is a good tool to estimate thirty-day mortality, although it may overestimate the risk in experienced aortic centers.

Source: Interdisciplinary Cardiovascular and Thoracic Surgery
Author(s): Katja Schumacher, Mateo Marin Cuartas, Manuela de la Cuesta, Thilo Noack, Philipp Kiefer, Sergey Leontyev, Michael A Borger, Marcel Vollroth, Martin Misfeld

The frequency of minimally invasive mitral valve (MV) surgery has increased over the last decade. Hence, the number of patients requiring MV reoperations post-minimally invasive MV surgery is increasing. This study analyzed the outcomes of patients undergoing MV reoperation after previous minimally invasive MV surgery during a twenty-year period in a high volume heart valve center. A total of 187 patients were included in the analysis (34 [18.2 percent] patients repeat MV repair; 153 [81.8 percent] MV replacement). Redo MV surgery was performed through median sternotomy in 169 (90.4 percent) patients. The median intensive care unit stay was 1 day (1-5 days). The thirty-day mortality was 6.4 percent, and actuarial survival at 5 and 12 years was 61.8 percent and 38.3 percent, respectively. Endocarditis and preoperative stroke were identified as predictors of late mortality.

Source: Journal of Clinical Medicine
Author(s): Salsano A, Di Mauro M, Labate L, Della Corte A, Lo Presti F, De Bonis M, Trumello C, Rinaldi M, Cura Stura E, Actis Dato G, Punt

Overall, 4,365 patients were diagnosed and operated on for infective endocarditis (IE) from 2000 to 2021. Long-term survival was significantly higher among patients receiving a mechanical prosthesis than those receiving a biological prosthesis (hazard ratio [HR] 0.546, 95 percent CI: 0.322-0.926, p= 0.025). Mechanical prostheses were associated with significantly less recurrent endocarditis after AVR than biological prostheses (HR 0.268, 95 percent CI: 0.077-0.933, p= 0.039). The present analysis of the INFECT-REGISTRY shows increased survival and reduced recurrence of endocarditis after a mechanical aortic valve prosthesis implant for IE in middle-aged patients.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Niels Michael Dörr, Marcus Krüger, Miriam Möller, Norman Zinne, Mario Toennies, Olaf Schega, Christoph Ritter, Steffen Decker, Antje Hölsken, Wolfgang Schütte, Christian Biancosino

This study aimed to evaluate the percentage of solitary fibrous pleural tumors presenting unfavorable clinical behavior to predict negative long-term outcomes. Although they are historically considered benign neoplasms, this retrospective review identified 25 percent of 74 patients displayed histological evidence of malignancy as per England criteria and the recurrence rate was 21 percent. The authors recommended the pathological differentiation of these tumors into pedunculated, well circumscribed, and sessile growth patterns. They also recommend that all nonpedunculated lesions should be classified as potentially aggressive.

Source: The Annals of Thoracic Surgery
Author(s): David Rekhtman, Francisca Bermudez, Dominique Vervoort, Leslie Kaze, Ceeya Patton-Bolman, JaBaris Swain

Many obstacles challenge cardiac surgery in low- and middle-income countries, despite unmet cardiac surgical needs. One challenge has been providing adequate follow up care to monitor anticoagulation, manage morbidity, and prevent mortality. This systematic review of 67 articles published between 2012 and 2022 describes outcomes after valvular cardiac surgery and focuses on strategies for prolonged follow up care in resource constrained settings.

Source: European Journal of Cardio-Thoracic Surgery
Author(s): Nabil Dib, Laurence Iserin, Shaida Varnous, Romain Guillemain, Sebastien Hascoet, Emre Belli, Sarah Cohen

Heart transplantation (HT) is the only life extending option in adults with congenital heart disease (CHD) and end stage heart failure. This study evaluated outcomes after heart transplantation in adults with univentricular versus biventricular CHD. One-hundred-forty-nine patients were included, 55 of whom (36.9 percent) had univentricular CHD. Follow up was for a mean of 10.1 years. Sixty-four patients died during follow up, including 47 before discharge from hospital. Multivariable analysis showed univentricular physiology (odds ratio (OR) 2.99, 95 percent CI 1.33–6.74) and female recipient gender (OR 2.76, 95 percent CI 1.23–6.74) carried higher risk of early mortality. For patients who survived the early period, long-term survival was excellent and did not differ between the groups.

Source: European Heart Journal
Author(s): Jeroen J Bax, Rebecca T Hahn, Nina Ajmone Marsan, Helmut Baumgartner

In this brief review article, the authors discuss the pros and cons of early intervention in patients with moderate aortic valve stenosis.